0000950170-25-044347.txt : 20250325 0000950170-25-044347.hdr.sgml : 20250325 20250325160009 ACCESSION NUMBER: 0000950170-25-044347 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250321 FILED AS OF DATE: 20250325 DATE AS OF CHANGE: 20250325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PASSERI DANIEL R CENTRAL INDEX KEY: 0001190121 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 25768177 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 ownership.xml 4 X0508 4 2025-03-21 false 0001645460 Cue Biopharma, Inc. CUE 0001190121 PASSERI DANIEL R C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 true true false false CHIEF EXECUTIVE OFFICER false Stock Option (right to buy) 0.99 2025-03-21 4 A false 450000 0.0 A 2035-03-20 Common Stock 450000 450000 D This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025. /s/ Daniel Passeri by Colin Sandercock, attorney-in-fact 2025-03-25